2m 2m 2m 2m 2m 2m 2m
ORUKA THERA (ORKA)
NASDAQ
$90.33+$10.18 (+12.70%)
Price as of Oct 26, 2026 4:31 PM EDT- $5.3BMarket Cap
- 194.13%1-Year Change
- BiotechnologyIndustry
ORUKA THERA (ORKA)
$90.33+$10.18 (+12.70%)
ORKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $80.15 | ||
Change | -$1.00 (-1.23%) | ||
Open | $81.15 | ||
High | $81.15 | ||
Low | $79.07 | ||
Previous Close | $81.15 | ||
Volume | 513,995 | ||
30-Day Average Volume | 961,441 | ||
1-Week Change | 11.43% | ||
1-Month Change | -10.87% | ||
1-Year Change | 194.13% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $1.1B | ||
Market Cap | $5.3B | ||
Enterprise Value | $5.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.2M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$41.2M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $861.6M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -122 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -146 | ||
PEG | 10 | ||
Price/Free Cash Flow | -160 | ||
Price/Operating Cash Flow | -160 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue